Objective: To investigate the diagnostic performance of multiparametric magnetic resonance imaging (mpM-RI) in differentiating prostate cancer (PCa) from prostatitis foci.
Introduction
Prostatitis is caused by infiltration of the prostate tissue by immune mediators. Although most cases of prostatitis are not detected due to the subclinical course, similar to prostate cancer (PCa), prostatitis is a common disease, with a prevalence ranging from 2.2% to 9.7% [1] . Bacterial prostatitis is easy to identify, whereas non-bacterial prostatitis is a diagnostic challenge for urologists [2] . Similar to PCa, prostatitis exhibits an increase in serum prostate-specific antigen (PSA) levels and benign hyperplasia [3] . For this reason, it is difficult for urologists to distinguish PCa from benign pathologies with PSA. Owing to the lack of specific laboratory tests for the diagnosis of prostatitis, radiological imaging is the most commonly used diagnostic method.
Tissue changes that are hypointense on T2-weighted imaging (T2WI) may cause difficulties in diagnosing PCa. In addition to PCa, other possible causes of hypointensity on T2WI include prostatitis, hemorrhage, scarring, and atrophy, as well as the effects of various therapies [2, 4, 5] .
Given these possibilities, radiologists must make difficult decisions. Among the diagnostic alternatives, prostatitis is the most problematic condition due to the clinical and magnetic resonance (MR)-based similarities between it and PCa. Certain findings, such as wedge-shaped areas that show early contrast enhancement, absence of mass effect, and preservation of capsular integrity, are important to distinguish prostatitis from PCa [2, 4, 5] ; however, in routine practice, the distinction of these two diseases is not always possible. Thus, a biopsy, which is critical, is needed for a definitive diagnosis, and its results will affect treatment options. However, technical developments in the imaging arena have introduced the possibility of a non-invasive diagnosis.
Multiparametric MR imaging (mpMRI) has been developed because the diverse information obtained from a single MR sequence cannot adequately detect and characterize PCa alone. Examination of the prostate gland with mpMRI emerged approximately 10 years ago [6] . Prostate gland mpMRI, which is still being updated, aims to distinguish PCa using a combination of several MR sequences. The combination of T2WI, diffusion-weighted imaging (DWI), and dynamic contrast-enhanced imaging (DCEI) provides a systematic method of conducting decision-making processes and a focus on biopsy staging in a more objective manner. However, the information obtained is open to the subjective evaluation of the radiologist who determines the relative possibilities of a differential diagnosis. For this reason, more objective criteria are needed in the evaluation of diagnostic alternatives. To distinguish PCa from prostatitis using mpMRI, the criteria used must be both measurable and consistent. In recent years, apparent diffusion coefficient (ADC) measurements have distinguished between prostatitis and PCa [3] . Esen et al. [7] examined the ability of lower b values to discriminate PCa and prostatitis and showed that increased b values result in decreased sensitivity and increased specificity in the differentiation of PCa from prostatitis.
The aim of the present study was to compare the mpMRI-based measurements obtained from the foci of PCa and prostatitis and to determine the diagnostic performance of MR sequences and the combination of sequences used to differentiate these two disorders.
Materials and Methods

Subjects
The institutional review board of Ankara University School of Medicine approved this retrospective, single-center study protocol and waived informed consent.
One hundred consecutive patients who underwent 3.0 Tesla prostate mpMRI between October 2011 and August 2015 and had a prostate biopsy after MR examination were enrolled in the study. Patients were referred to MR examination due to an elevated PSA level, a family history of PCa, or a suspicion of PCa at physical examination. Inclusion criteria were: (1) presence of high image quality prostate MR imaging before biopsy, (2) existence of biopsyproven prostatitis or PCa, and (3) no history of previous treatment administered to the pelvis. Unenhanced images of three patients with a history of an allergy to contrast material were also included in the study. Twelve patients with both prostatitis and PCa confirmed by pathology, eight patients with suboptimal MR images (extensive artifacts due to motion or rectal gas), and three patients with a history of previous prostate surgery or pelvis radiotherapy were excluded from the study. Of 100 patients, 77 patients with 81 biopsy-proven lesions (44 prostatitis (mean age 65±8 years) and 37 PCa (mean age 63±7 years)) met the inclusion criteria and were enrolled in our study.
MR Imaging
Before prostate biopsy, MR images were obtained using a 3.0 Tesla system (Verio; Siemens Medical Solutions, Erlangen, Germany). A standard body matrix coil was utilized for signal reception. The multiparametric detection and localization examination consisted of T1-weighted (T1W) images, high-resolution (HR) T2WI, DWI, and DCEI. In the present study, the sequences and planes reviewed were as follows: HR T2W sagittal, coronal, and axial turbo spinecho (TSE) images; DWI with three different b values (0, 1000 and 2000 mm 2 /s) obtained in the axial plane using a single-shot multi-slice echo-planar imaging sequence with spectral adiabatic inversion recovery fat suppression; ADC maps, which were automatically generated using a monoexponential decay model including all three b values using Siemens Software Version syngo MR B17; and DCEI images. Before the injection of contrast material, an axial threedimensional (3D) T1W gradient-echo (GRE) sequence was used to allow the calculation of relative gadolinium chelate concentration curves. During intravenous administration of 0.2 mL/kg of gadolinium chelate at an injection rate of 2.5 mL/s, followed by a 15 mL saline flush, dynamic images were acquired in the axial plane with a 3D fat-suppressed GRE T1W sequence. With this sequence, the entire prostatic volume was repeatedly imaged every 7 s, with the same positioning angle and center as the axial T2W sequence. Then, contrast-enhanced fatsuppressed T1W TSE oblique axial and oblique coronal images were acquired. Table 1 shows the pulse sequence parameters utilized in our study.
MRI Analysis
Diagnostic MR images were analyzed using Workstation (Leonardo; Siemens Medical Solutions, Erlangen, Germany) from which DCEI parameters were calculated. Images of all patients were reviewed by three radiologists with 10 years (E.P. and D.S.) and 2 years (H.E.A.) of experience in prostate MRI who were blinded to the clinical history and histology results. Since this was a retrospective study, biopsy results were correlated with MR images to determine the site of normal tissue, PCa, and prostatitis. For this purpose, one of the authors (A.E.) searched the biopsy results and defined and tabulated the location of the prostate lesion in each patient; however, she did not give any information to the reviewers about the nature of the lesion. She also retrieved data regarding the PSA levels of the patients from the hospital information system.
Initially, prostate volumes were measured and recorded by the reviewers, and PSA/prostate volumes were calculated. The MRI criteria used for the assessment of Prostate Imaging, Reporting and Data System, version 2 (PIRADSv2), as well as signal intensity (SI) on DWI, were evaluated in the present study. After localization of the lesion on MRI, SIs were measured three times on T2WIs and DWIs (b=1000 and b=2000 mm The three types of enhancement kinetic curves were assessed as follows: type 1 (progressive enhancement pattern), type 2 (plateau pattern), and type 3 (washout pattern) [8] . A continuous SI increase within the first 3 min was defined as a type I curve. The washout percentage was calculated using the following formula: (peak SI−SI at the end of the examination)/peak SI×100. Lesions with a washout percentage of >3.15% (cut-off value determined from receiver operating characteristic (ROC) curve analyses) were classified as a type 3 curve; others were accepted as having a plateau pattern and classified as a type 2 curve. The contrast enhancement percentage was calculated using the following formula: (peak SI−SI at the beginning of the examination)/SI at the beginning of the examination×100. Regions of interest were defined by tracing a line freehand around the perceived tumor margins. Since the objectives of the present study did not include the staging of PCa, scoring according to the PIRADS was not performed.
The mean values of each parameter were compared. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and false-negative rate of significantly different parameters of the two groups (nT2SI, DWI (b=2000 mm 2 /s), ADC values, washout percentage) and their combinations in differentiating prostatitis and PCa were determined. Combinations of these statistically significant parameters were classified as follows: (1) all criteria should be positive for PCa diagnosis, (2) two combined criteria were acceptable for PCa diagnosis, and (3) three combined criteria were acceptable for PCa. ROC curves were generated, and area under the curve (AUC) was used to determine how nT2SIs and SI on DWIs (b=2000 mm 2 /s), ADC values, and washout percentages operated as discriminatory tests to distinguish prostatitis and PCa. The cut-off values for each of these parameters were determined.
Biopsy
After MRI (maximum 2 weeks later), core biopsies were obtained from 12 sections of the prostate gland (four quadrants each at the base, mid-gland, and apex), as well as from the target lesion suspected on MRI.
Statistical Analysis
The results are expressed as mean±standard deviation for continuous variables. Age followed a normal distribution, and groups (PCa vs. prostatitis) were compared using Student's t-test. PSA value, prostate volume, and PSA/ prostate volume followed non-normal distributions, and comparisons between the two groups (PCa vs. prostatitis) were performed using Mann-Whitney U test. Among the MRI data, for the comparison of normal and PCa tissue in the PCa group, normally distributed values (nT2SI, SI on DWI b=1000 mm 2 /s, and SI at the end of the dynamic curves) were compared using paired t-test, and non-normally distributed values (ADC values, SI on DWI b=2000 mm 2 /s, and peak SI at the dynamic curves) were compared using Wilcoxon test. In the prostatitis group, for the comparison of normal and prostatitis tissue, normally distributed values (nT2SI and ADC values) were compared using paired t-test, and non-normally distributed values (SI on DWI b=1000 mm 2 /s and b=2000 mm 2 /s, peak SI at the dynamic curves, and SI at the end of the dynamic curves) were compared using Wilcoxon test. For comparisons between the PCa and prostatitis groups, normally distributed nT2SI and ADC values were compared using Student's t-test. Non-normally distributed SI on DWI b=1000 mm 2 /s and b=2000 mm 2 /s, peak SI at the dynamic curves, and SI at the end of the dynamic curves were compared using Wilcoxon test. The sensitivity, specificity, PPV, NPV, and false-negative rate of significantly dif- ferent parameters of the two groups (nT2SI, SI on DWI (b=2000 mm 2 /s), ADC values, and washout percentage) and their combinations in differentiating prostatitis and PCa were determined. ROC curves were generated, and AUC was used to determine how nT2SI and SIs on DWIs (b=2000 mm 2 /s), ADC values, and washout percentages and their combinations operated as discriminatory tests to distinguish prostatitis and PCa. The cut-off values for each of these parameters were determined. The frequency of curve types was compared using chi-square test.
Data analysis was made using the Statistical Package for the Social Sciences (SPSS Inc.; Chicago, IL, USA) 11.5 and MedCalc software (MedCalc, version 16; Mariakerke, Belgium). Biopsy results were accepted as the standard of reference. A p<0.05 was considered as significant.
Results
A total of 77 patients with biopsy-proven prostatitis or PCa between October 2011 and August 2015 were included in the study. Four patients had two lesions. There were 37 cancer-positive and 44 prostatitis-positive biopsy specimens. Table 2 shows the characteristics of the prostatitis and PCa groups. Age and PSA levels were not significantly different between the prostatitis and PCa groups (p=0.196). The mean prostate volume (65.1 mL vs. 43.6 mL, p<0.001) and mean PSA/prostate volume (0.29 vs. 0.16, p=0.003) were significantly higher in the PCa group than in the prostatitis group. Table 2) . After contrast medium injection, both peak SI (390 vs. 398 vs. 244) and SI at the end of the examination (347 vs. 370 vs. 274) were significantly higher in the PCa and prostatitis groups than in the normal tissue group (p<0.001, p<0.001, p<0.001, and p<0.001) ( Table 2 ). However, there was no significant difference between the PCa and prostatitis groups in terms of peak SI (390 vs. 398, p=0.862), SI at the end of the examination (347 vs. 370, p=0.388), and peak time (141 vs. 162 s, p=0.137) ( Table 2 ). The prostatitis and PCa groups showed similar contrast enhancement (p=0.336) ( Table 2 ), but the contrast washout percentage was significantly higher in the PCa group than in the prostatitis group (12 vs. 4, p=0.003), with a cut-off value of 3.15% and AUC of 0.69 (95% CI: 0.57-0.81) ( Table 3 ).
The ROC curves of the nT2SIs, ADC values, SI on DWI (b=2000 mm 2 /s), and washout percentage yielded AUCs of 0.69, 0.82, 0.68, and 0.69, respectively (Table 3) . Among all the criteria, the mean ADC values showed both high sensitivity (80.5%, 95% CI: 64-92) and specificity (75%, 95% CI: 60-87) in addition to low false-negative rates (18%) ( Table 3 ). The cut-off values for each of the parameters are listed in Table 3 .
The ADC values demonstrated a moderate positive correlation with nT2SI (r=0.404, p=0.000), a moderate negative correlation with SI on DWI (b=2000 mm 2 /s) (r=−0.403, p=0.000), and a weak negative correlation with washout percentage (r=−0.332, p=0.003). The washout percentage showed a weak positive correlation with SI on DWI (b=2000 mm 2 /s) (r=0.325, p=0.005).
A type 1 curve was significantly more frequent in prostatitis cases than in PCa cases (p=0. (Figure 1) , whereas a type 3 curve was more frequently observed in PCa than in prostatitis ( Figure 1 ). The frequencies of curve types, determined by a cut-off value of 3.15% (cut-off value determined from ROC curve analyses) according to the lesion, are summarized in Figure  1 . The AUC was calculated as 0.69 (95% CI: 0.57-0.81, p=0.003) when the washout percentage was 3.15%, and a type 3 curve was accepted as favoring PCa.
By using the cut-off values for discriminating patients with PCa, the diagnostic performance of the combinations of four criteria (nT2SI, ADC, DWI at b=2000 mm 2 /s, and washout percentage) was calculated ( Table 3 ). The combination of nT2SI, ADC value, and washout percentage (positivity in two out of the three criteria was accepted as sufficient for a diagnosis of PCa) yielded both higher sensitivity and specificity, as well as the highest AUC (0.81, 95% CI: 0.71-0.91) ( Table 3) . MR images of biopsy-proven prostatitis and PCa are shown in Figures 2 and  3 , respectively.
Discussion
The ability to accurately differentiate prostatitis from PCa is critical to manage patients and avoid unnecessary treatment. As shown in our study, increased prostate and PSA/prostate volumes were clinical indicators of prostatitis and PCa. However, imaging is generally needed for differential diagnosis. When examining studies of PCa, data regarding the differentiation between PCa and prostatitis are limited [2, 3] .
Our results highlight several important issues and difficulties with regard to the discrimination of prostatitis from PCa using MRI. T2WIs are generally used for the evaluation of the prostate. However, as mentioned above, the specificity of T2WI is low [2, 9] .
The evidence presented in the presented study suggests that both PCa and prostatitis can be distinguished from normal tissue using the ADC values, nT2SI, and SI on DWI (b=2000 mm 2 /s). However, prostatitis cannot be discriminated from normal tissue by an SI of b=1000 mm 2 /s.
As previously indicated, diffusion values lower than b=1400 mm 2 /s are not recommended in prostate imaging [9] .
In the present study, four parameters were examined to distinguish between prostatitis and PCa. These parameters included nT2SI, SIs on DWI (b=2000 mm 2 /s), ADC values, and washout percentage. Among these four criteria, the ADC values showed the highest AUC, high sensitivity and specificity, and low false-negative rates. The ADC values also showed a positive correlation with nT2SI and a negative correlation with SI on DWI (b=2000 mm 2 /s) and washout percentage, as expected.
Compared with prostatitis, PCa showed higher SI on DWI (b=2000 mm 2 /s), lower nT2SI, and lower ADC values. Moreover, the washout percentage of PCa was higher than that of prostatitis.
The diagnostic accuracy of ADC measurements appears to be higher than that of T2WI, which is standard in prostate imaging. Overlap of the enhancement characteristics between PCa and benign prostatic hypertrophy has been previously described [10] [11] [12] . PCa is known to exhibit variable contrast kinetics [2] . Moreover, some malignant tumors show early washout, and some continue to enhance progressively [2] . In the 2015 version of PIRADS, this potential diagnostic limitation of DCEI was emphasized [9] , and we made a similar observation. Quantitative DCEI parameters, such as time to peak and mean enhancement percentage, were not distinguishing factors between PCa and prostatitis. In our study, compared with prostatitis, PCa often demonstrated early enhancement; however, there was no significant difference in peak time, which may be due to the heterogeneity of the PCa group demonstrated by both low-and highgrade tumors. However, the washout percentage appeared to be a better discriminator of PCa (AUC: 0.69, 95% CI: 0.57-0.81).
It remains unclear which criteria can be used to determine the curve type [9] . Based on the results of our study, we suggest that lesions with any of the curve types other than the type 1 curve should raise suspicion of PCa. When a washout percentage of 3.15% and a type 3 The differentiation of PCa from prostatitis remains a problem characterized by low sensitivity and specificity values. For this reason, in the present study, we sought to increase the diagnostic efficiency by combining different criteria. When all evaluated criteria were expected to be positive, all criteria added to the ADC values reduced the sensitivity of the ADC and increased the false-negative rates. If two out of the three criteria were positive, they were accepted as sufficient for the diagnosis of PCa. The combination of nT-2SI, ADC values, and washout percentage (cutoff value 3.15% and type 3 curve) increased the specificity of the ADC values and reduced the false-negative rate. In addition, the adoption of all curves other than the type 1 curve in favor of PCa alone was sufficient for high sensitivity. Furthermore, the combination of this finding with nT2SI and ADC values did not change the sensitivity and specificity, and the combination of all highlighted criteria (nT2SI, SI on DWI at b=2000 mm 2 /s, ADC values, and washout percentage) did not markedly improve the sensitivity of ADC and reduced the specificity. Combinations with DWI (b=2000 mm 2 /s) did not increase the sensitivity of nT2SIs, ADC values, or the washout percentage but increased the false-negative rates.
Despite a consensus indicating diffusion restriction, there was substantial variation in the reported ADCs of PCa [3] . As our study results demonstrated, the average ADCs differed significantly between normal tissue, PCa, and prostatitis ( /s, respectively). In contrast to our study, the study by Esen et al. [7] did not show significant differences between the mean ADC values of normal tissue and prostatitis at b values of 100, 600, and 1000 mm 2 /s. This result may be due to relatively lower b values selected in their study; thus, emphasis should be placed on the importance of using higher b values in prostate imaging.
Our study had several limitations. First, this was a retrospective study with a relatively small sample size. Second, the lack of classification of pathology specimens as low-grade and highgrade PCa is another limitation. Finally, most importantly, there was a potential for incorrect estimation of biopsy-proven lesions on MRI because the biopsy was not MR guided.
In conclusion, mpMRI of the prostate gland at 3.0 Tesla enabled differentiation between normal tissue, PCa, and prostatitis. nT2SI, SI on DWI (b=2000 mm 2 /s), ADC values, and washout percentage were identified as MRI criteria for discriminating PCa from prostatitis. Compared with all of the single and most of the combined criteria, the ADC values alone demonstrated higher sensitivity and specificity. Moreover, the combination of nT2SI, ADC values, and washout percentage (at least two positive criteria were sufficient for a diagnosis of PCa) yielded the highest sensitivity and specificity among all combinations. The use of anatomic and functional MRI sequences revealed a difference between prostatitis and PCa. However, caution should be exercised when interpreting these results, and the weaknesses of each sequence should be realized and taken into consideration when making decisions regarding the results.
